Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2545 | 2212 | 37.6 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
468 | 3 | GLUCOSINOLATES//BILIRUBIN//HEME OXYGENASE | 24157 |
1434 | 2 | BILIRUBIN//HYPERBILIRUBINEMIA//KERNICTERUS | 7874 |
2545 | 1 | UDP GLUCURONOSYLTRANSFERASE//GLUCURONIDATION//UDP GLUCURONOSYLTRANSFERASES UGTS | 2212 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UDP GLUCURONOSYLTRANSFERASE | authKW | 1835728 | 12% | 51% | 263 |
2 | GLUCURONIDATION | authKW | 1130628 | 11% | 35% | 235 |
3 | UDP GLUCURONOSYLTRANSFERASES UGTS | authKW | 392601 | 1% | 89% | 32 |
4 | UGT1A6 | authKW | 326892 | 1% | 79% | 30 |
5 | UGT2B7 | authKW | 294419 | 2% | 53% | 40 |
6 | UDP GLUCURONOSYLTRANSFERASE UGT | authKW | 271934 | 1% | 73% | 27 |
7 | UGT | authKW | 268778 | 3% | 35% | 56 |
8 | UGT1A9 | authKW | 256953 | 1% | 58% | 32 |
9 | JOINT TRANSLAT MED | address | 208601 | 1% | 66% | 23 |
10 | DRUG METABOLISM AND DISPOSITION | journal | 196952 | 15% | 4% | 327 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 22492 | 58% | 0% | 1289 |
2 | Toxicology | 1586 | 9% | 0% | 192 |
3 | Biochemistry & Molecular Biology | 1247 | 23% | 0% | 512 |
4 | Biophysics | 460 | 6% | 0% | 139 |
5 | Chemistry, Medicinal | 224 | 4% | 0% | 83 |
6 | Genetics & Heredity | 94 | 4% | 0% | 93 |
7 | Gastroenterology & Hepatology | 77 | 3% | 0% | 58 |
8 | Oncology | 64 | 5% | 0% | 112 |
9 | Endocrinology & Metabolism | 64 | 3% | 0% | 75 |
10 | Biochemical Research Methods | 22 | 2% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOINT TRANSLAT MED | 208601 | 1% | 66% | 23 |
2 | CONTRACEPT DEVICES NPFPC | 111335 | 0% | 73% | 11 |
3 | CANADA CHAIR PHARMACOGENOM | 98584 | 0% | 71% | 10 |
4 | PHARMACEUT OURCE DISCOVERY | 93510 | 2% | 18% | 38 |
5 | CANADA CHAIR PHARMACOGEN | 88334 | 0% | 80% | 8 |
6 | DRUG METAB DRUG DISPOSIT GRP | 61479 | 0% | 64% | 7 |
7 | COMPARAT MOL PHARMACOGEN | 57509 | 0% | 83% | 5 |
8 | SECT GENET DISORDERS DRUG METAB | 55210 | 0% | 100% | 4 |
9 | COMPARAT MOL PHARMACOGENET | 55206 | 0% | 67% | 6 |
10 | ONCOL MOL ENDOCRINOL | 51410 | 2% | 11% | 34 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 196952 | 15% | 4% | 327 |
2 | LATIN AMERICAN JOURNAL OF PHARMACY | 78015 | 5% | 5% | 117 |
3 | DRUG METABOLISM AND PHARMACOKINETICS | 33690 | 2% | 6% | 42 |
4 | XENOBIOTICA | 18396 | 3% | 2% | 72 |
5 | DRUG METABOLISM REVIEWS | 13284 | 1% | 3% | 31 |
6 | BIOCHEMICAL PHARMACOLOGY | 12109 | 6% | 1% | 128 |
7 | PHARMACOGENETICS AND GENOMICS | 10189 | 1% | 3% | 29 |
8 | PHARMACOGENETICS | 7026 | 1% | 2% | 22 |
9 | MOLECULAR PHARMACOLOGY | 5006 | 3% | 1% | 60 |
10 | COMPREHENSIVE BIOCHEMISTRY | 2299 | 0% | 17% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UDP GLUCURONOSYLTRANSFERASE | 1835728 | 12% | 51% | 263 | Search UDP+GLUCURONOSYLTRANSFERASE | Search UDP+GLUCURONOSYLTRANSFERASE |
2 | GLUCURONIDATION | 1130628 | 11% | 35% | 235 | Search GLUCURONIDATION | Search GLUCURONIDATION |
3 | UDP GLUCURONOSYLTRANSFERASES UGTS | 392601 | 1% | 89% | 32 | Search UDP+GLUCURONOSYLTRANSFERASES+UGTS | Search UDP+GLUCURONOSYLTRANSFERASES+UGTS |
4 | UGT1A6 | 326892 | 1% | 79% | 30 | Search UGT1A6 | Search UGT1A6 |
5 | UGT2B7 | 294419 | 2% | 53% | 40 | Search UGT2B7 | Search UGT2B7 |
6 | UDP GLUCURONOSYLTRANSFERASE UGT | 271934 | 1% | 73% | 27 | Search UDP+GLUCURONOSYLTRANSFERASE+UGT | Search UDP+GLUCURONOSYLTRANSFERASE+UGT |
7 | UGT | 268778 | 3% | 35% | 56 | Search UGT | Search UGT |
8 | UGT1A9 | 256953 | 1% | 58% | 32 | Search UGT1A9 | Search UGT1A9 |
9 | UGTS | 155329 | 1% | 49% | 23 | Search UGTS | Search UGTS |
10 | UGT2B15 | 142378 | 1% | 74% | 14 | Search UGT2B15 | Search UGT2B15 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HU, DG , MEECH, R , MCKINNON, RA , MACKENZIE, PI , (2014) TRANSCRIPTIONAL REGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE GENES.DRUG METABOLISM REVIEWS. VOL. 46. ISSUE 4. P. 421 -458 | 282 | 63% | 11 |
2 | ROWLAND, A , MINERS, JO , MACKENZIE, PI , (2013) THE UDP-GLUCURONOSYLTRANSFERASES: THEIR ROLE IN DRUG METABOLISM AND DETOXIFICATION.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 45. ISSUE 6. P. 1121-1132 | 104 | 75% | 128 |
3 | TRIPATHI, SP , BHADAURIYA, A , PATIL, A , SANGAMWAR, AT , (2013) SUBSTRATE SELECTIVITY OF HUMAN INTESTINAL UDP-GLUCURONOSYLTRANSFERASES (UGTS): IN SILICO AND IN VITRO INSIGHTS.DRUG METABOLISM REVIEWS. VOL. 45. ISSUE 2. P. 231-252 | 159 | 72% | 6 |
4 | RADOMINSKA-PANDYA, A , BRATTON, S , LITTLE, JM , (2005) A HISTORICAL OVERVIEW OF THE HETEROLOGOUS EXPRESSION OF MAMMALIAN UDP-GLUCURONOSYLTRANSFERASE ISOFORMS OVER THE PAST TWENTY YEARS.CURRENT DRUG METABOLISM. VOL. 6. ISSUE 2. P. 141-160 | 143 | 87% | 34 |
5 | ODA, S , FUKAMI, T , YOKOI, T , NAKAJIMA, M , (2015) A COMPREHENSIVE REVIEW OF UDP-GLUCURONOSYLTRANSFERASE AND ESTERASES FOR DRUG DEVELOPMENT.DRUG METABOLISM AND PHARMACOKINETICS. VOL. 30. ISSUE 1. P. 30 -51 | 141 | 46% | 31 |
6 | RICHES, Z , COLLIER, AC , (2015) POSTTRANSCRIPTIONAL REGULATION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 11. ISSUE 6. P. 949 -965 | 103 | 83% | 3 |
7 | STINGL, JC , BARTELS, H , VIVIANI, R , LEHMANN, ML , BROCKMOLLER, J , (2014) RELEVANCE OF UDP-GLUCURONOSYLTRANSFERASE POLYMORPHISMS FOR DRUG DOSING: A QUANTITATIVE SYSTEMATIC REVIEW.PHARMACOLOGY & THERAPEUTICS. VOL. 141. ISSUE 1. P. 92-116 | 121 | 55% | 39 |
8 | FUJIWARA, R , YOKOI, T , NAKAJIMA, M , (2016) STRUCTURE AND PROTEIN-PROTEIN INTERACTIONS OF HUMAN UDP-GLUCURONOSYLTRANSFERASES.FRONTIERS IN PHARMACOLOGY. VOL. 7. ISSUE . P. - | 89 | 84% | 1 |
9 | TUKEY, RH , STRASSBURG, CP , (2000) HUMAN UDP-GLUCURONOSYLTRANSFERASES: METABOLISM, EXPRESSION, AND DISEASE.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 40. ISSUE . P. 581 -616 | 90 | 65% | 910 |
10 | HU, DG , MACKENZIE, PI , MCKINNON, RA , MEECH, R , (2016) GENETIC POLYMORPHISMS OF HUMAN UDP-GLUCURONOSYLTRANSFERASE (UGT) GENES AND CANCER RISK.DRUG METABOLISM REVIEWS. VOL. 48. ISSUE 1. P. 47 -69 | 117 | 58% | 1 |
Classes with closest relation at Level 1 |